Prevalence and risk factors of retinopathy in an Asian population without diabetes: The Singapore Malay eye study

Archives of Ophthalmology

Volumn 128, Issue 1, 2010, Pages 40-45

  Jeganathan, V Swetha E ^a,b   Cheung, Ning ^a,c   Tay, Wan Ting ^b   Wang, Jie Jin ^a,d   Mitchell, Paul ^d   Wong, Tien Yin ^a,b,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ANAMNESIS; ARTICLE; ASIAN; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; RISK ASSESSMENT; RISK FACTOR; SINGAPORE; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; DIABETIC RETINOPATHY; ETHNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SINGAPORE;

EID: 75349092333     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.330     Document Type: Article

References (47)

1. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369(9559):425-435.
2. Wong TY, Mohamed Q, Klein R, Couper DJ. Do retinopathy signs in nondiabetic individuals predict the subsequent risk of diabetes? Br J Ophthalmol. 2006;90(3):301-303.
3. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112 (1):92-98.
4. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998;116(1): 83-89.
5. Stolk RP, Vingerling JR, de Jong PT, et al. Retinopathy, glucose, and insulin in an elderly population: The Rotterdam Study. Diabetes. 1995;44(1):11-15.
6. van Leiden HA, Dekker JM, Moll AC, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care. 2002;25(8):1320-1325.
7. Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P. Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye. 2006;20(11):1239-1245.
8. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people. Br J Ophthalmol. 2002;86(9):1007- 1013.
9. Venkatramani J, Mitchell P. Ocular and systemic causes of retinopathy in patients without diabetes mellitus. BMJ. 2004;328(7440):625-629.
10. Chao JR, Lai MY, Azen SP, Klein R, Varma R; Los Angeles Latino Eye Study Group. Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2007;48(9):4019-4025.
11. Svärdsudd K, Wedel H, Aurell E, Tibblin G. Hypertensive eye ground changes. Prevalence, relation to blood pressure and prognostic importance: the study of men born in 1913. Acta Med Scand. 1978;204(3):159-167.
12. Kawasaki R, Wang JJ, Wong TY, Kayama T, Yamashita H. Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population: the Funagata study. Diabetes Obes Metab. 2008;10(6):514-515.
13. Leibowitz HM, Krueger DE, Maunder LR. The Framingham Eye Study Monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(suppl):335-610.
14. Wong TY, Barr EL, Tapp RJ, et al. Retinopathy in persons with impaired glucose metabolism. Am J Ophthalmol. 2005;140(6):1157-1159.
15. West SK, Klein R, Rodriguez J, et al; Proyecto VER. Diabetes and diabetic retinopathy in a Mexican-American population. Diabetes Care. 2001;24(7):1204-1209.
16. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24(2):137-144.
17. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106(12):2269-2280.
18. Wong TY, Klein R, Sharrett AR, et al. The prevalence and risk factors of retinal microvascular abnormalities in older persons. Ophthalmology. 2003;110(4):658-666.
19. Liew G, Wong T, Mitchell P, Cheung N, Wang JJ. Retinopathy predicts coronary heart disease mortality. Heart. 2009;95(5):391-394.
20. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet. 2001;358 (9288):1134-1140.
21. Duncan BB, Wong TY, Tyroler HA, Davis CE, Fuchs FD. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol. 2002; 86(9):1002-1006.
22. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA. 2005;293(1):63-69.
23. Wong TY, Liew G, Tapp RJ, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes. Lancet. 2008;371(9614):736-743.
24. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis? Arterioscler Thromb Vasc Biol. 2000;20(6):1644-1650.
25. Foong AW, Saw SM, Loo JL, et al. Rationale and methodology for a populationbased study of eye diseases in Malay people: The Singapore Malay eye study (SiMES). Ophthalmic Epidemiol. 2007;14(1):25-35.
26. Lamoureux EL, Chong E, Wang JJ, et al. Visual impairment, causes of vision loss, and falls. Invest Ophthalmol Vis Sci. 2008;49(2):528-533.
27. Wong TY, Chong EW, Wong WL, et al; Singapore Malay Eye Study Team. Prevalence and causes of low vision and blindness in an urban Malay population: the Singapore Malay Eye Study. Arch Ophthalmol. 2008;126(8):1091-1099.
28. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869-1875.
29. Jeganathan VS, Kawasaki R, Wang JJ, et al. Retinal vascular caliber and agerelated macular degeneration: the Singapore Malay Eye Study [published online ahead of print August 30, 2008]. Am J Ophthalmol. 2008;146(6):954.e1- 959.e1.
30. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446-455.
31. Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye. 2007;21(4):465-471.
32. Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community: The Blue Mountains Eye Study. Ophthalmology. 1998;105(3): 406-411.
33. Klein R, Klein BE, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986;93(9):1183-1187.
34. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
35. Wong TY, Tielsch JM. A population-based study on the incidence of severe ocular trauma in Singapore. Am J Ophthalmol. 1999;128(3):345-351.
36. Saw SM, Chan YH, Wong WL, et al. Prevalence and risk factors for refractive errors in the Singapore Malay Eye Survey. Ophthalmology. 2008;115(10):1713-1719.
37. Sun C, Liew G, Wang JJ, et al. Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci. 2008;49(5):1784-1790.
38. Su DH, Wong TY, Wong WL, et al; Singapore Malay Eye Study Group. Diabetes, hyperglycemia, andcentral corneal thickness: the SingaporeMalayEyeStudy[published online ahead of print October 26, 2007]. Ophthalmology. 2008;115(6):964.e1-968.e1.
39. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9(suppl 4):228S-233S.
40. Shankar A, Leng C, Chia KS, et al. Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant. 2008;23(6):1910-1918.
41. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351(22):2310-2317.
42. Wong TY, Klein R, Duncan BB, et al. Racial differences in the prevalence of hypertensive retinopathy. Hypertension. 2003;41(5):1086-1091.
43. Jager A, van Hinsbergh VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes. 2000;49(3):485-491.
44. Jager A, van Hinsbergh VW, Kostense PJ, et al. von Willebrand factor, Creactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19(12):3071-3078.
45. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation. 1997;96(12):4219-4225.
46. van Hecke MV, Dekker JM, Nijpels G, et al. Inflammation and endothelial dysfunction are associated with retinopathy. Diabetologia. 2005;48(7):1300-1306.
47. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res. 2008;27(2):161-176.